Resource Types Drug Development Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs